bacteri
viral
coinfect
communityacquir
pneumonia
cap
poorli
character
adult
aim
studi
investig
influenc
bacteri
viral
coinfect
patient
cap
total
adult
request
molecular
test
pneumonia
diagnos
cap
enrol
studi
microbiolog
test
includ
blood
sputum
cultur
pcr
bacteri
viral
pathogen
antigen
test
streptococcu
pneumonia
influenza
viru
antibodi
detect
mycoplasma
pneumonia
patient
patient
coinfect
bacteria
viru
among
sever
cap
patient
concurr
infect
confirm
patient
proport
sever
pneumonia
significantli
higher
patient
coinfect
show
significantli
higher
mortal
rate
conclus
bacteri
viral
coinfect
cap
rare
occurr
adult
viral
bacteri
coinfect
advers
impact
sever
pneumonia
increas
morbid
mortal
patient
cap
pneumonia
acut
infecti
diseas
still
one
common
caus
death
world
world
health
organ
report
lower
respiratori
infect
caus
million
death
worldwid
world
health
organ
particular
pneumonia
mortal
rate
substanti
higher
children
five
adult
year
age
communityacquir
pneumonia
cap
type
pneumonia
develop
peopl
limit
contact
healthcar
system
incid
cap
vari
age
countri
gender
howev
clinic
impact
cap
clear
patient
cap
often
requir
hospit
cap
increas
mortal
welt
et
al
wunderink
water
cap
caus
variou
pathogen
bacteria
virus
fungu
parasit
case
cap
caus
singl
pathogen
welt
et
al
develop
diagnost
techniqu
variou
pathogen
effect
detect
clinic
sampl
huijsken
et
al
jen
et
al
clinic
characterist
mix
infect
cap
describ
sever
report
chiu
et
al
cilloniz
et
al
jen
et
al
possibl
correl
mix
infect
sever
diseas
report
howev
data
clinic
featur
bacteri
viral
coinfect
especi
adult
patient
cap
still
limit
therefor
retrospect
investig
adult
hospit
patient
cap
analyz
incid
etiolog
clinic
featur
outcom
bacteri
viral
coinfect
patient
studi
retrospect
analysi
hospit
patient
cap
refer
molecular
diagnosi
pneumonia
use
blood
sputum
urin
specimen
chungang
univers
hospit
januari
decemb
studi
approv
institut
review
board
chungang
univers
hospit
sampl
collect
patient
molecular
diagnosi
pneumonia
subject
classifi
accord
age
medic
record
patient
year
older
review
patient
suspect
healthcareassoci
pneumonia
hcap
hospitalacquir
pneumonia
hap
exclud
studi
hcap
hap
patient
classifi
accord
infecti
diseas
societi
america
idsa
american
thorac
societi
at
guidelin
at
idsa
confirm
patient
diagnos
cap
cap
defin
pneumonia
base
british
thorac
societi
bt
guidelin
lim
et
al
patient
includ
studi
cap
primari
reason
hospit
manag
pneumonia
subsequ
lim
et
al
pneumonia
sever
index
psi
fine
et
al
calcul
record
time
admiss
subject
addit
sever
pneumonia
patient
classifi
accord
idsaat
guidelin
mandel
et
al
subject
enrol
studi
follow
data
collect
basic
patient
inform
age
sex
hospit
period
mortal
rate
past
medic
histori
comorbid
diseas
malign
congest
heart
failur
cerebrovascular
diseas
renal
diseas
liver
diseas
chronic
obstruct
pulmonari
diseas
copd
bronchiectasi
asthma
previou
mycobacteria
infect
histori
hiv
human
immunodefici
viru
infect
histori
physic
find
bodi
temperatur
heart
rate
blood
pressur
respiratori
rate
mental
statu
laboratori
find
bacteri
cultur
result
specimen
bacteri
viral
antigen
test
molecular
test
result
bacteri
viral
pathogen
antibodi
test
pneumonia
hiv
screen
assay
arteri
blood
ga
analysi
abga
complet
blood
cell
count
cbc
blood
nitrogen
urea
bun
sodium
glucos
creactiv
protein
crp
chest
radiograph
find
mechan
ventil
immunocompromis
statu
intens
care
unit
icu
admiss
addit
chest
comput
tomographi
bronchoscopi
find
also
collect
avail
time
hospit
blood
urin
sputum
nasopharyng
swab
specimen
collect
microbiolog
examin
blood
cultur
perform
aerob
anaerob
use
bactalert
blood
cultur
system
inc
marcyletoil
franc
vitek
system
inc
use
bacteri
identif
sputum
sampl
gramstain
examin
follow
accept
suitabl
quantit
cultur
leukocyt
per
microscop
field
visibl
epitheli
cell
suitabl
sputum
specimen
cultur
blood
agar
plate
macconkey
agar
specimen
bronchoalveolar
lavag
fluid
cerebrospin
fluid
pleural
punctur
tracheobronchi
aspir
collect
cultur
avail
pcr
detect
bacteri
viral
pathogen
nasopharyng
swab
specimen
examin
use
seeplex
pneumobact
ace
detect
pneumobact
seegen
seoul
south
korea
anyplex
ii
detect
seegen
system
qualit
pcr
assay
pneumobact
could
detect
six
common
lower
respiratori
tract
infect
pathogen
streptococcu
pneumonia
haemophilu
influenza
chlamydophila
pneumonia
legionella
pneumophila
bordetella
pertussi
mycoplasma
pneumonia
realtim
pcrbase
common
pathogen
caus
respiratori
infect
could
detect
includ
adenoviru
influenza
b
parainfluenza
viru
rhinoviru
abc
respiratori
syncyti
viru
rsv
b
bocaviru
metapneumoviru
coronaviru
enteroviru
antibodi
test
pneumonia
pneumonia
elisa
kit
zeu
scientif
nj
usa
test
pair
serum
sampl
fourfold
increment
serum
igg
consid
caus
pathogen
addit
hiv
screen
assay
architect
hiv
agab
combo
abbott
laboratori
wiesbaden
germani
urinari
streptococcu
pneumonia
antigen
test
sd
biolin
strep
strip
aler
usa
rapid
influenza
antigen
test
sd
biolin
influenza
ag
aler
perform
data
enter
microsoft
excel
microsoft
wa
usa
analyz
use
spss
ibm
corp
ny
usa
valu
present
median
interquartil
rang
continu
variabl
count
percentag
categor
variabl
compar
continu
variabl
mannwhitney
utest
use
fisher
exact
test
perform
compar
differ
categor
variabl
pvalu
less
consid
signific
differ
multivari
logist
regress
analysi
employ
identifi
risk
factor
bacteri
viral
coinfect
select
final
model
use
stepwis
backward
select
entri
probabl
remov
probabl
baselin
characterist
physic
find
laboratori
find
previou
medic
histori
includ
analyz
risk
factor
depend
variabl
addit
similar
statist
analysi
perform
identifi
independ
variabl
associ
mortal
patient
refer
pneumonia
molecular
test
major
pediatr
patient
adult
patient
enrol
studi
review
medic
record
cap
diagnosi
could
establish
adult
subject
among
total
pathogen
bacteri
pathogen
viral
pathogen
confirm
identifi
patient
distribut
pathogen
summar
tabl
commonli
identifi
bacteri
pathogen
streptococcu
pneumonia
haemophilu
influenza
chlamydophila
pneumonia
addit
two
bacteri
pathogen
isol
patient
found
coinfect
viral
pathogen
viru
frequent
confirm
virus
rhinoviru
influenza
viru
adenoviru
infect
multipl
virus
found
four
patient
coinfect
bacteri
pathogen
frequent
identifi
viru
caus
bacteri
viral
coinfect
rsv
result
concurr
infect
total
six
patient
tabl
show
characterist
patient
cap
patient
cap
patient
diagnos
viral
bacteri
coinfect
basic
patient
inform
past
medic
histori
comorbid
diseas
physic
laboratori
find
compar
without
bacteri
viral
coinfect
signific
differ
found
bronchiectasi
p
previou
nontubercul
mycobacteria
ntm
infect
p
bodi
temperatur
p
percentag
neutrophil
p
absolut
neutrophil
count
p
crp
p
differ
score
pneumonia
sever
index
subject
without
coinfect
proport
patient
met
idsaat
sever
pneumonia
criteria
significantli
higher
patient
coinfect
p
addit
coinfect
patient
show
longer
hospit
stay
higher
mortal
rate
howev
signific
differ
found
mortal
rate
p
signific
associ
coinfect
bacteri
viral
pathogen
mortal
rate
tabl
show
signific
associ
concurr
infect
patient
cap
bronchiectasi
previou
ntm
infect
strong
predispos
factor
coinfect
physic
laboratori
find
associ
coinfect
studi
likelihood
mortal
increas
age
respiratori
rate
wbc
crp
idsaat
sever
pneumonia
presenc
bacteri
viral
coinfect
decreas
puls
rate
hemoglobin
tabl
cap
play
signific
role
caus
death
adult
worldwid
world
health
organ
asia
cap
estim
caus
approxim
million
death
per
year
peto
et
al
mani
studi
conduct
detect
etiolog
adult
cap
howev
studi
focus
pneumonia
caus
bacteri
viral
pathogen
cilloniz
et
al
peto
et
al
concurr
infect
pathogen
poorli
studi
therefor
clinic
impact
bacteri
viral
coinfect
adult
cap
fulli
investig
studi
one
studi
focu
etiolog
bacteri
viral
concurr
infect
confirm
clinic
signific
find
indic
half
adult
patient
cap
evid
infect
one
bacteria
andor
virus
patient
cap
could
classifi
bacteri
viral
coinfect
anoth
studi
adult
patient
cap
bacteri
viral
coinfect
identifi
patient
jen
et
al
among
sever
cap
patient
bacteri
viral
coinfect
confirm
patient
studi
result
similar
previou
report
show
sever
cap
critic
ill
patient
karhu
et
al
martinloech
et
al
voiriot
et
al
find
suggest
least
one
tenth
adult
cap
patient
one
fifth
sever
cap
patient
suffer
bacteri
viral
concurr
infect
similar
previou
report
rhinovirus
frequent
identifi
viral
pathogen
adult
patient
cap
huijsken
et
al
lieberman
et
al
templeton
et
al
wiemken
et
al
studi
commonli
identifi
viral
pathogen
caus
concurr
coinfect
rsv
differ
previou
report
jen
et
al
believ
differ
could
caus
mani
factor
differ
racial
background
geograph
factor
howev
due
limit
number
coinfect
patient
avail
analysi
could
confirm
patient
prognosi
might
chang
depend
combin
caus
viral
bacteri
pathogen
problem
address
addit
larg
cohort
studi
multivari
logist
regress
analysi
found
bronchiectasi
previou
ntm
infect
risk
factor
bacteri
viral
coinfect
suspect
structur
lung
abnorm
would
effect
bacteri
viral
coinfect
howev
remain
unclear
factor
would
affect
coinfect
comparison
coinfect
group
group
differ
baselin
characterist
physic
find
bodi
temperatur
neutrophil
percentag
count
crp
higher
bacteri
viral
coinfect
patient
cap
clinic
prognosi
differ
distribut
psi
howev
proport
idsaat
sever
pneumonia
mortal
rate
higher
bacteri
viral
coinfect
cap
group
group
without
coinfect
addit
data
show
concurr
infect
bacteri
viral
pathogen
identifi
one
signific
risk
factor
independ
associ
mortal
find
consist
result
previou
report
cawcutt
kalil
martinloech
et
al
voiriot
et
al
would
suggest
concurr
bacteri
viral
infect
would
directli
associ
sever
symptom
wors
prognosi
find
support
patient
coinfect
bacteria
viru
might
show
wors
clinic
cours
mix
infect
could
poor
prognost
factor
adult
cap
sever
possibl
reason
result
first
interact
bacteria
virus
would
underli
pathogenesi
cap
wellknown
synerg
exist
influenza
pneumonia
klein
et
al
mcculler
bacterialvir
interact
would
fatal
pneumonia
patient
increas
mortal
dramat
variou
viral
mechan
disrupt
epitheli
barrier
upregul
adhes
protein
dysfunct
immun
system
could
facilit
bacteri
infect
bosch
et
al
morri
et
al
assum
synerg
could
play
role
worsen
pneumonia
second
patient
cap
treat
appropri
antimicrobi
therapi
howev
antivir
agent
limit
treatment
adult
pneumonia
patient
confirm
caus
viral
pathogen
requir
support
care
treatment
could
prevent
viral
replic
suspect
would
associ
worsen
outcom
adult
patient
cap
except
bacteri
tabl
characterist
two
group
without
bacteri
viral
coinfect
communityacquir
pneumonia
coinfect
influenza
chertow
memoli
morri
et
al
howev
role
antivir
agent
bacteri
viral
coinfect
patient
cap
yet
elucid
although
attempt
minim
error
sever
limit
exist
studi
follow
first
natur
retrospect
studi
reli
chart
review
patient
inform
limit
obtain
detail
patient
inform
socioeconom
factor
lifestyl
physic
psychiatr
statu
previou
hospit
histori
second
although
variou
test
perform
identifi
pathogen
caus
cap
limit
discov
caus
pathogen
addit
possibl
methodolog
issu
could
made
difficult
detect
everi
bacteri
viral
coinfect
third
medic
record
track
diseas
histori
patient
cap
hospit
stay
admit
clinic
outcom
could
misjudg
studi
due
voluntari
discharg
transfer
hospit
euthanasia
larg
prospect
research
need
resolv
present
limit
confirm
result
studi
conclus
demonstr
adult
patient
cap
coinfect
bacteria
viru
clear
concurr
coinfect
uncommon
fact
coinfect
may
advers
impact
sever
pneumonia
increas
effect
morbid
adult
patient
cap
howev
addit
clinic
studi
conduct
gain
better
insight
etiolog
clinic
role
bacteri
viral
coinfect
